The 8th #MedSafetyWeek starts today! This year again, along with more than 80 countries around the world, the Institute for Medicines and Medical Devices (CInMED) participates in the campaign that is carried out via social networks under the leadership of the Uppsala Monitoring Centre (UMC). The campaign takes place from 6 to 12 November 2023, with the aim of emphasizing the important role of patients and healthcare professionals in safe use of medicines.
The theme of this year’s campaign is “Who can report?” Medicines are safe and efficient, but may cause adverse reactions in certain patients. Competent regulatory institutions in the field of medicines, CInMED in Montenegro, establish a system for continuous monitoring of safety of medicines, with the aim of collecting new information on adverse reactions that are already known and timely detection of new ones.
The system for adverse reactions to medicines reporting is used to detect, collect and analyze the reports on suspected adverse reactions, in order to prevent their manifestation whenever possible.
Every report sent by a patient, or a healthcare professional is important as it contributes to creating a true picture of safety and efficacy of a medicine. When necessary, with the aim of patients’ protection, CInMED takes adequate regulatory measures that may improve prescribing practices and treatment outcomes.
We hope that this campaign will encourage healthcare professionals and patients to report suspected adverse reactions to medicines, as this increases knowledge about medicines, making them safer for all of us.
Don’t miss the educational material prepared for the #MedSafetyWeek campaign that will be published during the week on CInMED social media and YouTube.
More detailed information on how to report adverse reactions are available in the section Pharmacovigilance/Adverse reactions to medicines reporting.
